Article

Clinical and Genomic Determinants of Survival in EGFR-Mutant Non-Small Cell Lung Cancer: An Integrated Analysis of UK Biobank and cBioPortal Cohorts

2026-04-07

Abstract excerpt

<title>Abstract</title> <p>Background Prognostic heterogeneity in EGFR-mutant non-small cell lung cancer (NSCLC) remains incompletely understood. Although differences between EGFR mutation subtypes have been widely reported, the extent to which co-occurring genomic alterations contribute to survival variability remains unclear. Methods We conducted an integrated analysis combining population-based clinical data...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e9fbc8c9-a6d1-5ca2-8c56-879fdf323468
DOI: 10.21203/rs.3.rs-9194785/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical and Genomic Determinants of Survival in EGFR-Mutant Non-Small Cell Lung Cancer: An Integrated Analysis of UK Biobank and cBioPortal CohortsDOI 10.21203/rs.3.rs-9194785/v1Read

Co-mutation landscape and prognostic impact of genomic complexity in EGFR-mutant non-small cell lung cancerSemantic proximity Read

Retrospective study on the clinicogenomic characteristics of <i>EGFR</i> mutant and wildtype NSCLCSemantic proximity Read

Pooled Analysis of the Prognostic Significance of Epidermal Growth Factor Receptor (EGFR) Mutational Status in Combination with Other Driver Genomic Alterations in Stage I Resected Invasive Lung Adenocarcinoma for Recurrence-Free Survival: A Population-Based Study.Semantic proximity Read

A Radio-Genomics Biomarker for Precision Epidermal Growth Factor Receptor Mutation Targeting Therapy in Non-Small Cell Lung CancerSemantic proximity Read

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing.Semantic proximity Read

Genomic Signatures Define Three Subtypes of EGFR-Mutant Stage II-III NSCLC With Distinct Adjuvant Therapy OutcomesSemantic proximity Read

Multivariable Modelling Reveals EGFR Copy Number as an Independent Predictor of Survival in LUADSemantic proximity Read

Prognostic value of tumor mutation burden in non-small cell lung cancer: A Meta-Analysis and system reviewSemantic proximity Read

Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitors.Semantic proximity Read

A radio-genomics biomarker for precision epidermal growth factor receptor mutation targeting therapy in non-small cell lung cancer.Semantic proximity Read

Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC.Semantic proximity Read

The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review.Semantic proximity Read